An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.

Abstract excerpt

UNLABELLED: Approximately 5% of nonmedullary thyroid cancers are of familial origin. When two or more family members are diagnosed with nonmedullary thyroid cancer in the absence of other known associated syndromes it is termed familial nonmedullary thyroid cancer (FNMTC). The genetic inheritance of FNMTC remains unknown, but it is believed to be an autosomal dominant mode of inheritance with incomplete...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age of Onset
• Share to Biopsy, Fine-Needle
• Share to Evidence-Based Medicine